Table 3.
Open in new tab

Groups of Causes of Inpatient Hospitalization Among HIV-Infected Drug Users

Groups of CausesTotal Group No. (%)HIV-1 RNA 50 < Copies/mL No. (%)HIV-1 RNA 50 > Copies/mL No. (%)P
Bacterial infections97 (59.2%)31 (41.3%)66 (54.1%).081
Chronic end-organ damage33 (16.8%)27 (36.0%)6 (4.9%).0000
Complications derivates of IDU33 (16.%)4 (5.3%)29 (23.8%).0008
Malignancies18 (9.1%)12 (12.0 %)6 (7.4%).277
AIDS opportunistic infections13 (6.6%)2 (1.3%)12 (9.8%).019
HAART secondary effects3 (1.5%)3 (4.0%)0 (0.0%).026
Groups of CausesTotal Group No. (%)HIV-1 RNA 50 < Copies/mL No. (%)HIV-1 RNA 50 > Copies/mL No. (%)P
Bacterial infections97 (59.2%)31 (41.3%)66 (54.1%).081
Chronic end-organ damage33 (16.8%)27 (36.0%)6 (4.9%).0000
Complications derivates of IDU33 (16.%)4 (5.3%)29 (23.8%).0008
Malignancies18 (9.1%)12 (12.0 %)6 (7.4%).277
AIDS opportunistic infections13 (6.6%)2 (1.3%)12 (9.8%).019
HAART secondary effects3 (1.5%)3 (4.0%)0 (0.0%).026

Abbreviations: AIDS, acquired immune deficiency syndrome; ART, antiretroviral therapy; HAART, highly active ART; HIV, human immunodeficiency virus; IDU, intravenous drug use.

Table 3.
Open in new tab

Groups of Causes of Inpatient Hospitalization Among HIV-Infected Drug Users

Groups of CausesTotal Group No. (%)HIV-1 RNA 50 < Copies/mL No. (%)HIV-1 RNA 50 > Copies/mL No. (%)P
Bacterial infections97 (59.2%)31 (41.3%)66 (54.1%).081
Chronic end-organ damage33 (16.8%)27 (36.0%)6 (4.9%).0000
Complications derivates of IDU33 (16.%)4 (5.3%)29 (23.8%).0008
Malignancies18 (9.1%)12 (12.0 %)6 (7.4%).277
AIDS opportunistic infections13 (6.6%)2 (1.3%)12 (9.8%).019
HAART secondary effects3 (1.5%)3 (4.0%)0 (0.0%).026
Groups of CausesTotal Group No. (%)HIV-1 RNA 50 < Copies/mL No. (%)HIV-1 RNA 50 > Copies/mL No. (%)P
Bacterial infections97 (59.2%)31 (41.3%)66 (54.1%).081
Chronic end-organ damage33 (16.8%)27 (36.0%)6 (4.9%).0000
Complications derivates of IDU33 (16.%)4 (5.3%)29 (23.8%).0008
Malignancies18 (9.1%)12 (12.0 %)6 (7.4%).277
AIDS opportunistic infections13 (6.6%)2 (1.3%)12 (9.8%).019
HAART secondary effects3 (1.5%)3 (4.0%)0 (0.0%).026

Abbreviations: AIDS, acquired immune deficiency syndrome; ART, antiretroviral therapy; HAART, highly active ART; HIV, human immunodeficiency virus; IDU, intravenous drug use.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close